Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,467,026
+$21,097,464 QoQ
Shares Held
320,612
+45.7% QoQ
Ownership
0.679%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $3,403,585,552 across 30 Diagnostics & Research names. BLLN ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,547,342 | $775,775,381 | |
| 2 | GH |
Guardant Health, Inc.
|
3,150,897 | $472,729,076 | |
| 3 | DHR |
Danaher Corp /De/
|
2,331,466 | $444,097,640 | |
| 4 | ILMN |
Illumina, Inc.
|
1,148,102 | $201,870,770 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
881,189 | $199,844,850 | |
| 6 | ICLR |
Icon PLC
|
979,596 | $170,165,619 | |
| 7 | WAT |
Waters Corp /De/
|
436,388 | $163,662,953 | |
| 8 | DGX |
Quest Diagnostics Inc
|
759,975 | $161,076,698 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,467,026 | 320,612 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,369,562 | 220,035 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,006,821 | 122,273 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||